신경변성질환의 신규 치료법 파트 II : 헌팅턴병, 루게릭병(HD 및 ALS)
Emerging Therapeutics for Neurodegenerative Diseases Part II: Huntington´s Disease and Amyotrophic Lateral Sclerosis (HD & ALS)
상품코드 : 913123
리서치사 : Frost & Sullivan
발행일 : 2019년 09월
페이지 정보 : 영문 71 Pages
US $ 4,950 ₩ 5,847,000
Web Access (Regional License) help
리서치사의 웹사이트에 로그인할 수 있는 패스워드가 발급되며, PDF를 다운로드 받는 형태로 제공됩니다. 동일 국가 내에 있는 사업장의 모든 분들이 이용할 수 있는 라이선스이며, 이용 인원수 제한은 없습니다. 텍스트 등의 PDF 내용 편집은 불가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


한글목차

현재 신경변성질환(Neurodegenerative Diseases)은 선진국의 주요 사인 1위입니다. 치료법이 적고 성공률도 상당히 낮습니다. 임상, 과학의 양 분야에서 신경변성질환의 치료와 진단을 위한 새로운 치료법 개발에 주력하고 있습니다.

세계 신경변성질환의 신규 치료법 시장에 대해 조사했으며, 기술적 동향과 이해관계자의 동향, 지역별 법규제 환경 등을 정리하여 전해드립니다.

제1장 개요

제2장 기술 환경과 동향

제3장 신경변성질환에 대처하기 위한 신규 치료법

제4장 기술 동향 리뷰와 평가

제5장 기술 레이더와 지능형 솔루션

제6장 시장 잠재성과 기술 도입

제7장 비지니스 환경과 지적재산 분석

제8장 업계 연락처

제9장 부록

KSA 19.10.11
영문 목차

영문목차

Novel Targeted Therapeutic Strategies Technologies Around Neurodegenerative Disorders - From Palliative to Future Interventions

At present, only a few therapies are available with relatively low success. Both, the clinical and the scientific communities are critically devoted to develop new therapeutic approaches to treat and diagnose neurodegenerative diseases.

At present days, neurodegenerative diseases represent one of the main causes of death in the industrialized economy. Overall characterized by a loss of neurons in particular regions of the nervous system, the subsequent decline in cognitive and motor function that patients experience in these diseases is associated with nerve cell loss.

The most common denominator among neurodegenerative diseases, in addition to nerve cell loss is inflammation. Although, a series of mutant genes and environmental toxins are related to neurodegenerative disorders, the causal mechanisms remain poorly understood.

Neurodegenerative diseases can be defined as multifactorial debilitating disorders of the nervous system. Overall, neurodegenerative diseases affect approximately 30 million individuals worldwide, according to the World Health Organization (WHO).

Factors Contributing to Neurodegenerative Diseases

The factors contributing to the onset of neurodegenerative diseases are multiple. Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), and amyotrophic lateral sclerosis (ALS) diseases are well-established as the consequence of misfolding and dysfunctional trafficking of proteins. However, other factors including mitochondrial dysfunction, oxidative stress, aging, and environmental issues are deeply associated with the onset of neurodegeneration.

Molecular Mechanisms Underlying Neurodegeneration

Although all these factors have been demonstrated to significantly contribute to the etiology of common neurodegenerative diseases, some molecular mechanisms underlying neurodegeneration remain unveiled.

Present efforts are focused on the identification of viable drug targets and biomarkers for early diagnosis of the diseases, in order to develop the best suited therapies.

Some Multifactorial Conditions to Watch:

Coverage of Neurodegenerative Diseases Technologies:

This research service, ‘Emerging Therapeutics for Neurodegenerative Diseases', focuses on the leading technology and business trends that are making possible the implementation of cutting-edge innovations that help to face the present and future challenges of the neurodegenerative disease therapeutics sector.

The tendencies depicted in this study will help to drive the sustainability of the neurodegenerative disease therapeutics industry by directly exhibiting the principal challenges faced by leading biopharmaceutical and biotechnology companies to develop new product modalities in an affordable and high performance style, while getting market acceptance and achieving market leadership by translating technology innovation to market competitiveness

The study covers the following topics:

An appendix is included, comprising lists of major industry influencers found in the field.

Table of Contents

1.0 Executive Summary

2.0 Technology Landscape and Trends

3.0 Emerging Therapies to Address Neurodegeneration

4.0 Technology Status Review and Assessment

5.0 Technology Radar and Intelligent Solutions

6.0 Market Potential and Technology Adoption

7.0 Business Landscape and Intellectual Property Analysis

8.0 Key Industry Contacts

9.0 Appendix

(주)글로벌인포메이션 02-2025-2992 koreainfo@gii.co.jp
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기